Adam Smith Conferences is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

The foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers

17 - 18 May 2016

Corinthia Saint-Petersburg Hotel

The Russian Pharmaceutical Forum will address fundamental questions for the industry’s leading GMs and executive teams, government and industry experts, academics and associations

Main Forum
17 - 18 May 

Topic-specific Conference 1
18 May

Topic-specific Conference 2
18 May

Russian Pharmaceutical Forum

More Details >>>

Pharmaceutical Production in Russia:
Current Status. Prospects. Partnerships
More Details >>>

Marketing strategies and digital communications:
Best practice for approach and delivery
More Details >>>

600+

Participants attend annually

100+

Key speakers from leading companies, the government and industry experts

60+

Topics covering all major issues to be discussed in 2016

fsgr4100

As an event partner, we will help you to forge new business relationships, share your experiences and position yourself as a go-to firm in your sector.

Don't miss your chance to get involved!
Click here for more information

smartphone tablet

The Russian Pharma application - online networking platform.

  • View the delegate list in advance
  • Send messages to fellow participants
  • Set up meetings
  • Search for CEO, Presidents and other senior managers' profiles

Live to all registered and paid conference attendees 2 weeks prior to the conference and 1 week after. Powered by Zerista.

Read more about networking.

Keynote and Spotlight Presentations at the Forum-2016

Giles Platford, President, Emerging Markets Business Unit, Takeda Pharmaceuticals
Giles Platford

President, Emerging Markets Business Unit

Takeda Pharmaceuticals

Chris Weafer, Senior Partner, Macro-Advisory Ltd
Chris Weafer

Senior Partner

Macro-Advisory Ltd

David Stuckler, Professor of Political Economy and Sociology, University of Oxford
David Stuckler

Professor of Political Economy and Sociology

University of Oxford

Evgeny Vinokurov, Founding Director, EDB Centre for Integration Studies
Evgeny Vinokurov

Founding Director

EDB Centre for Integration Studies

Douglas Thompson, Principal, The Thompson Consulting Group L.L.C.
Douglas Thompson

Principal

The Thompson Consulting Group L.L.C.

Zakhar Golant, Head of Board, The Union of Pharmaceutical and Biomedical Clusters
Zakhar Golant

Head of Board

The Union of Pharmaceutical and Biomedical Clusters

Martin  Gilman, Advisor to the Rector & Professor of Economics, Higher School of Economics
Martin Gilman

Advisor to the Rector & Professor of Economics

Higher School of Economics

Vadim Muzyayev, President, OJSC Protek
Vadim Muzyayev

President

OJSC Protek

Nenad Pavletic, General Manager, Roche Moscow
Nenad Pavletic

General Manager

Roche Moscow

Jo Pisani, Strategy& PwC, UK Pharma and Life Sciences Consulting Lead, PwC
Jo Pisani

Strategy& PwC, UK Pharma and Life Sciences Consulting Lead

PwC

Dmitry Pogrebinsky, General Director, CV Protek
Dmitry Pogrebinsky

General Director

CV Protek

Iskra Reic, General Manager, AstraZeneca Russia
Iskra Reic

General Manager

AstraZeneca Russia

Alexey Repik, Chairman of the Board, R-Pharm
Alexey Repik

Chairman of the Board

R-Pharm

Anthony Wong, General Manager, AbbVie Russia & CIS
Anthony Wong

General Manager

AbbVie Russia & CIS

Highlights of the Russian Pharmaceutical Forum 2016

Economic and Analytical Sessions

  • WHERE WILL GROWTH COME FROM?
    Market drivers and restraints, GDP & healthcare spending, pharmaceutical market analysis and forecast
  • ECONOMICS, BUSINESS CLIMATE, INVESTMENT ENVIRONMENT IN RUSSIA
    Panel discussion, featuring: World Bank, Higher School of Economics, Eurasian Development Bank, Eurasian Economic Commission

Read more >>>

 

CEO Vision for the Future

  • Economic, policy and business threats
  • Strengths of a multinational pharmaceutical industry
  • Building an effective partnership and a business model in the region
  • Contribution to creating a sustainable healthecare model in Russia

Read more >>>

Open Dialogue with the Regulator

  • State Duma and Ministry of Health:
    Recent year's regulatory developments
  • Ministry of Industry and Trade:
    Russia's Pharma 2020 – 2030  strategy realisation
  • Eurasian commission on: 
    What to expect from EEU?
  • FAS:
    pricing, IP and competition control measures

Read more >>>

Benefit from 2 topic-specific conferences - 18 May

pp in rus

Pharmaceutical Production in Russia: Current Status. Prospects. Partnerships

Topics for discussion:

  • Russia’s independence in supplying and manufacturing medical products
  • creating a competitive product with export potential
    development of contract production
  • opportunities for local manufacturers in emerging markets

Read more >>>

ms pic

Marketing strategies and digital communications: Best practice for approach and delivery

Topics for discussion:

  • What is missing in strategic marketing
  • Multichannel marketing
  • How does technology help marketers
  • Web strategies for pharmaceutical brands

Read more >>>

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

 

 

Watch highlights of the
Russian Pharamceutical Forum 2015